Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Developments in Viral Vector-Based Vaccines.

Ura T, Okuda K, Shimada M.

Vaccines (Basel). 2014 Jul 29;2(3):624-41. doi: 10.3390/vaccines2030624. Review.

2.

New insights into IL-12-mediated tumor suppression.

Tugues S, Burkhard SH, Ohs I, Vrohlings M, Nussbaum K, Vom Berg J, Kulig P, Becher B.

Cell Death Differ. 2015 Feb;22(2):237-46. doi: 10.1038/cdd.2014.134. Epub 2014 Sep 5. Review.

3.

Cellular immunotherapy using dendritic cells against multiple myeloma.

Nguyen-Pham TN, Lee YK, Lee HJ, Kim MH, Yang DH, Kim HJ, Lee JJ.

Korean J Hematol. 2012 Mar;47(1):17-27. doi: 10.5045/kjh.2012.47.1.17. Epub 2012 Mar 28.

4.

Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?

Kalinski P, Edington H, Zeh HJ, Okada H, Butterfield LH, Kirkwood JM, Bartlett DL.

Immunol Res. 2011 Aug;50(2-3):235-47. doi: 10.1007/s12026-011-8224-z.

5.

Engineering dendritic cells to enhance cancer immunotherapy.

Boudreau JE, Bonehill A, Thielemans K, Wan Y.

Mol Ther. 2011 May;19(5):841-53. doi: 10.1038/mt.2011.57. Epub 2011 Apr 5. Review.

6.

Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF.

Zhang SN, Choi IK, Huang JH, Yoo JY, Choi KJ, Yun CO.

Mol Ther. 2011 Aug;19(8):1558-68. doi: 10.1038/mt.2011.29. Epub 2011 Apr 5.

7.

Enhanced transduction and replication of RGD-fiber modified adenovirus in primary T cells.

Sengupta S, Ulasov IV, Thaci B, Ahmed AU, Lesniak MS.

PLoS One. 2011 Mar 28;6(3):e18091. doi: 10.1371/journal.pone.0018091.

8.

Gene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy.

Chen YZ, Yao XL, Tabata Y, Nakagawa S, Gao JQ.

Clin Dev Immunol. 2010;2010:565643. doi: 10.1155/2010/565643. Epub 2010 Dec 20. Review.

9.

Enhancement of dendritic cells as vaccines for cancer.

Turnis ME, Rooney CM.

Immunotherapy. 2010 Nov;2(6):847-62. doi: 10.2217/imt.10.56. Review.

10.

Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors.

Kalinski P, Okada H.

Semin Immunol. 2010 Jun;22(3):173-82. doi: 10.1016/j.smim.2010.03.002. Epub 2010 Apr 20. Review.

11.

Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4.

Kalinski P.

Curr Opin Investig Drugs. 2009 Jun;10(6):526-35. Review.

12.

Immunotherapy of cancer by IL-12-based cytokine combinations.

Weiss JM, Subleski JJ, Wigginton JM, Wiltrout RH.

Expert Opin Biol Ther. 2007 Nov;7(11):1705-21. Review.

Supplemental Content

Support Center